baber/WOPTO huggingface dataset:
Patent FI-872457-A0 (FI)
Inventor: MATHUR INDRESH
IPC: C25B9/19
Filed: 1987-06-02
Abstract: An electrolytic cell is disclosed which is particularly suited for the electrolysis of a brine solution to produce chlorine and caustic or the electrolysis of an aqueous alkali metal hydroxide to produce an aqueous alkaline hydrogen peroxide solution. The cell includes a frame for supporting a plurality of cell units extending in a vertical direction and, optionally, in a horizontal direction as well. Each cell unit includes a diaphragm in direct contact with one planar surface of a porous, self-draining cathode, and a current distributor in contact with an opposite planar surface of the cathode. Spacer means are provided btween the diaphragm and an anode to provide for effective circulation of electrolyte between the diaphragm and the anode. The cell is adapted for operation in a monopolar as well as a bipolar mode.
Patent FI-882866-A0 (FI)
Inventor: FRAZEE JAMES SIMPSON
IPC: C07C323/00
Filed: 1988-06-15
Abstract: Compounds of formula: <CHEM> in which, inter alia q is 0 to 2, R1 is (L)a-(CH2)b-(T)c-M wherein a and ca are 0 or 1, b is 3 to 14, L and T are independently O, S or CH2; and M is C1-4 alkyl, ethynyl, CF3, isopropenyl, furanyl, thienyl, cyclohexyl or optionally substituted phenyl; R2 and A are H, CF3, alkyl, alkoxy, halogen, OH, NO2, or NH2 or R1 and A are H and R2 is (L)a-(CH2)b-(T)c-M as above; y is COR3 or (CHX)n(CH2)p-Z wherein R3 is OH, NH2, aryloxy or alkoxy, n is 0 or 1, p is 0, 1 or 2; X is H, OH, alkyl, alkoxy or F, Z is COR3 or tetrazolyl; R is (CR5R6)dW, R5 and R6 are H or alkyl and W is an optionally substituted phenyl, pyridyl or pyrimidiyl group, intermediates and processes for their preparation and their use in therapy as leukotriene antagonists.
Patent FI-882947-A0 (FI)
Inventor: POULSEN OTTO MELCHIOR
IPC: A61Q11/00
Filed: 1988-06-20
Abstract: A bactericidal composition containing a hydrogen peroxide forming enzyme, particularly glucose oxidase and peroxidase, especially lactoperoxidase, a thiocyanate and lysozyme. During use hydrogen peroxide is generated which under the influence of the peroxidase converts the thiocyanate into hypothiocyanate (OSCN<->) attenuating bacteria in such a manner that they are lysed by the lysozyme. The composition is particularly appropriate in prophylaxis and treatment of gingivitis and paradentosis, in which cases it is used locally, e.g. applied as impregnating agent on tooth picks.
Patent FI-893601-A0 (FI)
Inventor: NINANE LEON
IPC: B01D9/00
Filed: 1989-07-27
Abstract: Process and plant for the crystallisation of an inorganic substance in which a supersaturated solution of the substance is forced to circulate through a fluidised-bed (14) reactor (2) after having passed through a distributor (12) maintained at a temperature at which the concentration of the supersaturated solution is lower than or equal to the concentration corresponding to saturation. The invention applies to the crystallisation of sodium chloride. <IMAGE>
Patent FI-915039-A0 (FI)
Inventor: STRID KENT
IPC: B05B15/534
Filed: 1991-10-25
Abstract: PCT No. PCT/SE90/00336 Sec. 371 Date Nov. 27, 1991 Sec. 102(e) Date Nov. 27, 1991 PCT Filed May 21, 1990 PCT Pub. No. WO90/15184 PCT Pub. Date Dec. 13, 1990.A spray tube nozzle adapted to be cleaned during its operation. The nozzle includes a nozzle head having an inlet connectable to a conduit and an outlet for spraying liquid. Within the nozzle head is located a rotatable element defining a through-hole. The through-hole is shaped in such a way that the opening at one end is of relatively small cross-section and at the opposite end of a relatively large cross-section. The rotatable element is sealingly arranged in the nozzle head and has an external groove. The rotatable element can be positioned in at least a first rotational position to facilitate flow of spraying liquid from the conduit, to the nozzle inlet, and through the through-hole in the rotatable element, to the nozzle outlet for forming spray jets at the outlet. A second rotational position allows liquid to be flushed through the conduit by flow of the spraying liquid from the inlet, through the groove, and exiting the nozzle through a flush hole. A third rotational position allows the through-hole to be flushed by the flow of spraying liquid from the nozzle inlet through the through-hole in a second direction opposite to the first direction.
Patent FI-930791-A0 (FI)
Inventor: ESCARGUEL HUGUES
IPC: B60N2/90
Filed: 1993-02-23
Abstract: The removable seat for a vehicle comprises a seat cushion, a backrest which can be folded down onto the seat cushion by tilting forwards and a substructure secured to the seat cushion and provided with means for removable fixing to the floor of the vehicle. The seat cushion and the backrest include a rigid shell (12, 16) which is open on the user side, containing at least one leaktight pouch (14, 18) provided with means for adjusting the pressure of a gas occupying the pouch. Such a seat can be used particularly in the back rows of seats of a people-carrier-type vehicle. <IMAGE>
Patent FI-934051-A0 (FI)
Inventor: STECHER VERA JOHANNA
IPC: A61P29/00
Filed: 1993-09-15
Abstract: The present invention provides (S)-(+)-Hydroxychloroquine substantially free of (R)-(-)-hydroxychloroquine, or a pharmaceutically acceptable acid-addition salt thereof, the use in the manufacture of a medicament for treatment of malaria, lupus erythematosus or rheumatoid arthritis and a composition containing it for the treatment of such diseases. The weight ratio of (S)-(+)-Hydroxychloroquine to (R)-(-)-hydroxychloroquine is preferably at least 90:10, most preferably at least 98:2.
Patent FI-944494-A0 (FI)
Inventor: BERGSTROEM ROLF ANDERS
IPC: G10L25/78
Filed: 1994-09-28
Abstract: A method and apparatus for encoding/decoding of background sounds. The background sounds are encoded/decoded in a digital frame based speech encoder/decoder. First, it is determined whether the signal that is directed to the encoder/decoder represents primarily speech or background sounds. When the signal directed to the encoder/decoder represents primarily background sounds, the temporal variation between consecutive frames and/or the domain of at least one filter defining parameter is restricted.
Patent FI-953779-A0 (FI)
Inventor: CALLEBERT FRANCK
IPC: C23C16/513
Filed: 1995-08-09
Abstract: A method for applying a thin film to a metal, organic or inorganic substrate (12), wherein a remote cold nitrogen plasma essentially consisting of free nitrogen atoms is produced in an enclosure (5) housing said substrate (12). To form passivation layers, a gaseous organosilica or germanium compound containing CH, Si (or Ge), O or NH groups is fed into said enclosure (5) during the formation of the remote nitrogen plasma. To form dielectric thin films, organometallic compounds may also be added.
Patent FI-961149-A0 (FI)
Inventor: SOLIMAN SAMIR S
IPC: H04J13/00
Filed: 1996-03-12
Abstract: A method and apparatus for simulating signal interference in one communication channel within a communication system, such as cellular or wireless subscriber telephone and/or data systems. The communication system may be of a cellular type in which users from a plurality of cells communicate information signals between one another using at least one base station and code division multiple access (CDMA) spread spectrum type communication signals. The base station is included in a first of the cells and has a transmitter from which information is transmitted to subscriber units over at least one communication channel. The disclosed method includes the step of determining a first composite signal energy associated with signal transmission from the base station transmitter over a first set of simulated communication channels. The simulation method further contemplates estimating a first average data rate for the first composite signal energy. Signal power transmitted over the one communication channel is adjusted in accordance with a first interference signal which is based on the first composite signal energy and first average data rate. In a preferred implementation, a determination is also made of a second composite signal energy associated with signal transmissions from base station transmitters in other cells over a second set of simulated communication channels. An estimate is also made of a second average data rate for the second composite signal energy to enable generation of a second interference signal.
Patent FI-961857-A0 (FI)
Inventor: CASTELHANO ARLINDO L
IPC: C07C69/533
Filed: 1996-05-02
Abstract: This invention is directed to compounds of formula (I): wherein R<1> is mercapto, acetylthio, carboxy, hydroxycarbamoyl, alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, benzyloxycarbamoyl or (i) (where R<6> is optionally substituted aryl, wherein the aryl group is quinol-2-yl, naphth-1-yl, naphth-2-yl, pyridyl or phenyl); R<2> is alkyl, aralkyl or cycloalkylalkyl; R<3> is cycloalkyl, alkyl (optionally substituted by cycloalkyl, hydroxy, mercapto, alkylthio, aralkoxy, carboxy, amino, alkylamino, guanidino, carbamoyl, pyridyl or indolyl), or aralkyl (optionally substituted by hydroxy, carboxy, alkyl or alkoxy); R<4> is nitro, amino, cyano, hydroxy, alkoxy, carboxy, alkoxycarbonyl, alkylsulfonyl, haloalkyl, alkoxycarbonylalkyl, tetrazolyl, carbamoyl (optionally substituted by alkyl or dialkylaminoalkyl), or aminosulfonyl (optionally substituted by alkyl); and R<5> is hydrogen, halo or hydroxy; as single stereoisomers or as mixtures thereof; or the pharmaceutically acceptable salts thereof. These compounds are useful in inhibiting matrix metalloprotease activity in mammals.
Patent FI-971791-A0 (FI)
Inventor: DENYER JONATHAN STANLEY HAROLD
IPC: A61M15/00
Filed: 1997-04-25
Abstract: PCT No. PCT/EP95/04254 Sec. 371 Date Jul. 14, 1997 Sec. 102(e) Date Jul. 14, 1997 PCT Filed Oct. 27, 1995 PCT Pub. No. WO96/13294 PCT Pub. Date May 9, 1996An apparatus for administering a fluid medicament to a patient in a gas for inhalation and for calculating the dosage administered to the patient comprising a holding member (1) for temporarily holding the medicament and gas prior to inhalation, means for introducing a quantity of the medicament into the holding chamber (1), a sensor (4) for detecting the introduction of the medicament into the holding chamber (1), detector means for detecting the rate of flow of gas inhaled by a patient from the holding chamber (1) and calculation means (25, 27, 29, 30, 31) operably connected to the sensor (4) and to the detector means for calculating the amount of medicament received by a patient. The calculating means (25, 27, 29, 30, 31) makes its calculation on the basis of the quantity of medicament released into the holding chamber (1), the volume of the holding chamber (1), the time elapsed from the detection of the introduction of the medicament, and the detected rate of flow of gas inhaled from the holding chamber (1). The calculation being made by assessing the concentration of the medicament in the holding chamber (1) on a time basis during reduction of the said concentration within the holding chamber (1), and be determining the volume of the gas received by the patient during inhalation, and the time elapsed from the detected introduction of medicament to the inhalation by the patient.
Patent FI-982280-A0 (FI)
Inventor: WESBY PHILIP
IPC: H04W72/08
Filed: 1998-10-21
Abstract: A method for a radio channel allocation for telecommunication networks, comprising fixed transceivers (BTS) and fixed or mobile radio stations (MS). The method comprises a step of performing channel allocation for a particular radio connection to a radio station based upon signal to interference estimates for the radio station. A system and a base station controller are also disclosed.
Patent IL-64277-A0 (IL)
Title: Apparatus for removal of integrated circuits from circuit boards
IPC: H05K13/04
Filed: 1981-11-11
Abstract: 1. Device for the desoldering of electronic components from printed circuit boards, having a device for melting the soldered joints, having a draw-off device comprising a resilient gripper, which is at least partially enclosed by a housing and which is fitted at a pull rod which stands under spring action, and having a device for removing solder residues from the bores of the printed circuit board, characterized in that the device for removing solder residues is formed from the housing (46) of the resilient gripper (36) and a compressed air duct (50), which is attached thereto and which is connected to a compressed air source, and in that the housing (46) entirely receives the resilient gripper (36) and the electronic component (80) and rests by its lower, circulating rim (47) on the printed circuit board (80).
Patent IL-72743-A0 (IL)
Title: 3-(piperidinyl)-and 3-(pyrrolidinyl)1h-indazoles,a process for their preparation and their use as a medicament
IPC: C07D401/00
Filed: 1984-08-28
Abstract: Novel 3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles, intermediates and processes for the preperation thereof, and their use for treating psychoses and alleviating pain are disclosed.
Patent IL-92489-A0 (IL)
Title: Cloning and expression of simian transforming growth factor-beta 1
IPC: C12N15/16
Filed: 1989-11-28
Abstract: Recombinant transforming growth factor- beta 1 (TGF- beta 1) is expressed to high levels in Chinese hamster ovary (CHO) cells using dihydrofolate reductase (dhfr) gene amplification. The expression plasmid was derived from the pSV2 vectors and contained, in tandem, the simian TGF- beta 1 and mouse dhfr cDNAs. Transcription of both cDNAs was controlled by the SV40 early promoter. Stepwise selection of transfected CHO cells in increasing concentrations of methotrexate yielded cell lines expressing amplified TGF- beta 1 nucleic acid sequences. The expression plasmid DNA was amplified greater than 35-fold in one of the methotrexate selected transfectants. The major proteins secreted by these cells consisted of latent TGF- beta 1 and TGF- beta 1 precursor polypeptides as judged by immunoblots using site-specific anti-peptide antibodies derived from various regions of the TGF- beta 1 precursor. Levels of recombinant TGF- beta 1 protein secreted by these cells approached 30 ug/24 hour/10<7> cells. Expression vectors encoding TGF- beta 1 precursor variants which direct the synthesis and secretion of TGF- beta 1 in transfected mammalian cells are also described.
Patent IL-92512-A0 (IL)
Title: Metallo-organic cobalt compounds and uses thereof
IPC: A61P35/00
Filed: 1989-12-01
Abstract: The present invention provides a complex compound having the structure:   <IMAGE>   wherein R1 and R1, are the same or different and each is an alkyl group, a phenyl group or a substituted derivative of a phenyl group; wherein R2 and R2, are the same or different and each is hydrogen, an unbranched alkyl group, a halide or a group having the structure   <IMAGE>   wherein R is hydrogen, an alkoxide group, an alkyl group, or OH; wherein R3 and R3, are the same or different and each is hydrogen or an alkyl group; wherein X and X' are the same or different and each is a water soluble group having weak to intermediate ligand field strength; and Q is a soluble, pharmaceutically acceptable negative ion. The invention also provides a method of treating a subject having a condition associated with the presence of free radicals in quantities sufficient to cause undesirable symptoms. A method of treating a wound or a burn and a method for treating a subject afflicted with tumor cells so as to cause regression of the tumor cells are also provided. These methods involve administering to the subject (or topically administering to the burn or wound) an effective amount of the compound. Furthermore the invention provides pharmaceutical compositions for the treatment of tumor cells in a subject or for the treating of undesirable symptoms associated with the presence of free radicals. The compositions comprising an effective amount of the compound and a pharmaceutically acceptable carrier. Also provided is an antimicrobial composition which comprises a suitable carrier and the compound in an amount effective to suppress the growth of microorganisms.
Patent AU-PN485095-A0 (AU)
Title: Process control
IPC: B29C48/92
Filed: 1995-08-18
Abstract: PCT No. PCT/AU96/00514 Sec. 371 Date Apr. 29, 1998 Sec. 102(e) Date Apr. 29, 1998 PCT Filed Aug. 16, 1996 PCT Pub. No. WO97/06940 PCT Pub. Date Feb. 27, 1997A method of expanding a tube of plastics material in which a longitudinally travelling tube is progressively diametrically expanded in internal fluid pressure in an expansion zone between an upstream plug and an expandable downstream plug. Expansion of the tube is controlled in response to parameters which directly or indirectly indicate variation in the relative velocity at which material is delivered to and removed from the expansion zone, such as detecting upstream velocity, early expansion diameter, axial force on a sizing device or the tube diameter just before the expansion zone.
Patent FI-20010742-A0 (FI)
Inventor: PARO DANIEL
IPC: F02M63/02
Filed: 2001-04-10
Abstract: A fuel injection valve comprising a needle valve assembly (2) arranged in a valve body (1), where a valve needle (2') is arranged to control the fuel injection into a cylinder (11) of an engine from a fuel chamber (5) arranged in the valve body (1). The fuel injection valve comprises a pressure sensing chamber (6) arranged in communication with the fuel chamber (5) and pressure measuring means (7) are arranged in communication with the pressure sensing chamber (6). The invention also relates to a method for fuel injection, wherein fuel is conducted at raised pressure, controlled by a valve needle (2') arranged in the valve body (1) from a fuel chamber (5) to a cylinder (11) of an engine, and wherein fuel is conducted from the fuel chamber (5) at raised pressure via pressure reducing means (9) arranged in the valve body to the pressure sensing chamber (6), where pressure measuring means (7) are arranged to monitor the operation of the injection valve.
Patent IL-128431-A0 (IL)
Title: Modular structure for aeroponic cultivations
IPC: A01G31/00
Filed: 1998-06-09
Abstract: PCT No. PCT/EP98/03441 Sec. 371 Date Feb. 3, 1999 Sec. 102(e) Date Feb. 3, 1999 PCT Filed Jun. 9, 1998 PCT Pub. No. WO98/56237 PCT Pub. Date Dec. 17, 1998A modular structure for aeroponic cultivations comprising a plurality of prefabricated side panels which are meant to receive plants being cultivated and a plurality of prefabricated flat bases to which the side panels are joined by means of respective interlock couplings in order to form a structure which is substantially shaped like an inverted V and in which the side panels are mutually connected along an upper ridge line by respective ridgecaps; a pumping unit and a spraying apparatus are also provided in order to feed an atomized nutrient solution inside the structure.
Patent IL-129415-A0 (IL)
Title: Sulphonyl benzazolones
IPC: A01N43/76
Filed: 1997-10-06
Abstract: Sulphonylbenzazolones of the formula  in which R1, R2, R3, R4, R5 and Q are each as defined in the description. a process for preparing these compounds and their use as microbicides in crop protection and in the protection of materials.
Patent IL-129849-A0 (IL)
Title: Bicyclic amine derivatives
IPC: C07D451/02
Filed: 1997-10-30
Abstract: The present invention concerns bicyclic amine derivatives of formula (I):    <IMAGE>  (I)  wherein R1 is an optionally substituted 5-membered heterocyclic ring system containing from 1 to 3 heteroatoms individually selected from nitrogen, oxygen and sulfur atoms, and at least one unsaturation (double bond) between adjacent atoms in the ring, wherein the substutuents, if present, are selected from halogen atoms, alkyl, alkenyl, alkynyl, alkoxy, haloalkyl, haloalkenyl, alkylthio and alkyl amino groups, any of which groups contain up to eight carbon atoms, and wherein two substituents may join to form a fused ring; R2 represents hydrogen or cyano or a group selected from alkyl, aryl, heteroaryl, aralkyl, heteroarylalkyl, alkenyl, aralkenyl, alkynyl, alkoxycarbonyl, alkanesulfonyl, arenesulfonyl, alkenyloxycarbonyl, aralkyloxycarbonyl, aryloxycarbonyl, heterocyclylalkyl, carbamyl, dithiocarboxyl or XR3 (where X represents oxygen or a group NR4), provided that when R2 is alkenyl, aralkenyl or alkynyl said group does not have an unsaturated carbon atom bonding directly to the ring nitrogen of formula (I); R3 and R4 are, independently, hydrogen, alkyl, aryl, heteroaryl, aralkyl, heteroarylalkyl, alkenyl, aralkenyl, alkynyl, heterocyclylalkyl, alkoxycarbonyl or carboxylic acyl; alkyl moieties of R2, R3 and R4 comprise from 1 to 15 carbon atoms, and are optionally substituted with one or more substituents selected from, halogen, cyano, carboxyl, carboxylic acyl, carbamyl, alkoxycarbonyl, alkoxy, alkylenedioxy, hydroxy, nitro, haloalkyl, alkyl, amino, acylamino, imidate and phosphonato groups; or an acid addition salt, quaternary ammonium salt or N-oxide derived therefrom; to processes for preparing them, to insecticidal compositions comprising them and to methods of using them to combat and control insect pests.
Patent IL-130524-A0 (IL)
Title: Stable liquid interferon formulations a kit containing the same and a process for stabilizing the same
IPC: A61K47/18
Filed: 1997-12-23
Abstract: Liquid interferon compositions having a pH between 4.0 and 7.2 are described. The compositions comprise interferon-beta and a stabilizing agent at between about 0.3 % and 5 % by weight which is an amino acid selected from the group consisting of acidic amino acids, arginine and glycine. If needed, salt is added to provide sufficient ionic strength. The liquid composition has not been previously lyophilized or previously cavitated. The liquid is preferably contained within a vessel having at least one surface in contact with the liquid that is coated with a material inert to adsorption of interferon-beta. A kit for parenteral administration of a liquid interferon formulation and a method for stabilizing liquid interferon compositions are also described.
Patent IL-131281-A0 (IL)
Title: Tumor necrosis factor (tnf) inhibitor and method for obtaining the same
IPC: C12N/
Filed: 1999-08-05
Abstract: At least two substantially purified tumor necrosis factor (TNF) inhibitors are disclosed which are glycoproteins that are active against TNF. The isolation of 30kDa and 40KDa TNF inhibitors from urine is disclosed. The deglycosylated form of the 30kDa TNF inhibitor and 40kDa TNF inhibitor are described as being active against TNF. The 40kDa TNF inhibitor is active against both TNF alpha and TNF beta. The amino acid sequence of the 30kDa TNF inhibitor and the 40kDa TNF inhibitor are disclosed. Methods for isolating the TNF inhibitors from human U937 cell medium are also described. <IMAGE>
Patent IL-145213-A0 (IL)
Title: Polyurethane solutions containing allkoxysilane structural units
IPC: C08G18/10
Filed: 2000-03-21
Abstract: The invention relates to polyurethane solutions with alkoxysilane structural units, processes for the preparation of polyurethane solutions containing alkoxysilane structural units and the use of polyurethane solutions containing alkoxysilane structural units.
Patent IL-147900-A0 (IL)
Title: Ascididemin derivatives and their therapeutic applications
IPC: C07D471/14
Filed: 2000-08-11
Abstract: The invention concerns a pharmaceutical composition comprising an efficient amount of a compound selected among the compounds of formulae (I) and (Ia) wherein: R1, R2, R3, R4, R5, R6 and R7 are as defined in Claim 1. Said compounds have interesting cytotoxic properties leading to a therapeutic use as antitumoral medicines.
Patent IL-149625-A0 (IL)
Title: Process for the preparation of n-carboxyanhydrides
IPC: C07D263/44
Filed: 2002-05-14
Abstract: In the preparation of N-carboxy-anhydrides (I), by reaction of a corresponding  alpha -,  beta - or  gamma -aminoacid (or its salt) with phosgene, diphosgene and/or triphosgene in a solvent medium, reaction is carried out at a pressure of less than 1000 mbar (preferably 960 mbar or less).